Abstract Details
|
Viet-Huong Nguyen, PharmD, MPH, MS
(Chapman University School of Pharmacy)
PRESENTER |
No disclosure on file |
| Reyna Duron, MD (UCLA/VA Medical Center) | No disclosure on file |
| Roberto Michelucci, MD (IRCCS-Institute of Neurological Sciences, Bellaria Hospital) | No disclosure on file |
| No disclosure on file | |
| Sanjib Sinha, MD (Dept of Neuro/NIMHANS) | No disclosure on file |
| Ahmad A. Beydoun, MD (University of Michigan Med Ctr) | No disclosure on file |
| Maher Arabi, MD (Chaleur Regional hospital) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Inna Keselman, MD, PhD (UCLA) | Dr. Keselman has nothing to disclose. |
| Iris E. Martinez-Juarez, MD (Instituto Nacional de Neurología y Neurocirugía) | No disclosure on file |
| Laura Guilhoto, MD | No disclosure on file |
| Javier Salas-Puig | No disclosure on file |
| No disclosure on file | |
| Elinor Ben-Menachem, MD, FAAN (Dept of Clinical Neuroscience) | Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Ben-Menachem has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Acta Neurologica Scandinvica. The institution of Dr. Ben-Menachem has received research support from zogenic. |
| No disclosure on file | |
| Berge A. Minassian, MD (Univeristy of Texas Southwestern Medical Center) | No disclosure on file |
| Jose M. Serratosa, MD, PhD (Unidad De Epilepsia/Servicio De Neurologia) | No disclosure on file |
| Antonio V. Delgado-Escueta, MD (VA GLAHS and UCLA) | No disclosure on file |